NOVAVAX INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-351.7M | $1.52B |
| FY2022 | — | $-634.1M | $1.34B |
| FY2023 | — | $-716.9M | $568.5M |
| FY2024 | — | $-623.8M | $530.2M |
| FY2025 | — | $-127.8M | $240.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-351.7M | $1.52B |
| FY2022 | — | $-634.1M | $1.34B |
| FY2023 | — | $-716.9M | $568.5M |
| FY2024 | — | $-623.8M | $530.2M |
| FY2025 | — | $-127.8M | $240.6M |